(Q48343728)

10 February 2018

title

Does agomelatine block 5-HT2C receptors in humans? (English)

1 reference

10 February 2018

Ann L Sharpley

1

0 references

Philip Cowen

object named as

Philip J Cowen

5

0 references

author name string

Nancy B Rawlings

2

1 reference

10 February 2018

Susannah Brain

3

1 reference

10 February 2018

Sarah F B McTavish

4

1 reference

10 February 2018

publication date

21 August 2010

1 reference

10 February 2018

published in

Psychopharmacology

1 reference

10 February 2018

volume

213

1 reference

10 February 2018

issue

2-3

1 reference

10 February 2018

page(s)

653-655

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-010-1993-6

exact match

0 references

cites work

Agomelatine treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1993-6

Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1993-6

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1993-6

Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1993-6

Effect of pharmacologic treatments on the sleep of depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1993-6

Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1993-6

Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1993-6

Increased slow wave sleep with 5-HT2 receptor antagonists: detection by ambulatory EEG recording and automatic sleep stage analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1993-6

Low dose melatonin improves sleep in healthy middle-aged subjects

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20730417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Major depressive disorder, sleep EEG and agomelatine: an open-label study.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20730417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20730417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00213-010-1993-6

1 reference

10 February 2018

1 reference

10 February 2018